Needs Assessment for Mohs Micrographic Surgery

Dermatologic Clinics

Volumn 30, Issue 1, 2012, Pages 167-175

  Asgari, Maryam M ^a,b   Olson, Jonathan M ^c   Alam, Murad ^d  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Mohs micrographic surgery; Needs assessment; Skin cancers

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AZITHROMYCIN; CEFALEXIN; CEFDINIR; CLINDAMYCIN; CLOPIDOGREL; DICLOXACILLIN; DIPYRIDAMOLE; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADENOID CYSTIC CARCINOMA; ADNEXA DISEASE; ANGIOSARCOMA; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANT THERAPY; ANTICOAGULATION; APOCRINE CARCINOMA; BACTEREMIA; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CHEMOSURGERY; COST EFFECTIVENESS ANALYSIS; CURETTAGE; DERMATOFIBROSARCOMA PROTUBERANS; ECCRINE POROCARCINOMA; FIBROXANTHOMA; FROZEN SECTION; GINGER; GINKGO BILOBA; HISTOLOGY; HUMAN; KERATOACANTHOMA; LEIOMYOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MELANOMA; MERKEL CELL TUMOR; NEEDS ASSESSMENT; OUTCOME ASSESSMENT; PAGET SKIN DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SEBACEOUS CARCINOMA; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TISSUE PRESERVATION; TREATMENT INDICATION;

DERMATOLOGY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MOHS SURGERY; NEEDS ASSESSMENT; SKIN NEOPLASMS; UNITED STATES;

EID: 82455220836     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.08.010     Document Type: Review

References (73)

1. Shriner D.L., McCoy D.K., Goldberg D.J., et al. Mohs micrographic surgery. J Am Acad Dermatol 1998, 39(1):79-97.
2. Otley C.C., Salasche S.J. Mohs surgery: efficient and effective. Br J Ophthalmol 2004, 88(9):1228.
3. Available at: Accessed July 5, 2011. http://www.medicarenhic.com/pa/policies/MOHS%20Micrographic%20Surgery%20(L26371).pdf.
4. Pugliano-Mauro M., Goldman G. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2010, 36(10):1544-1553.
5. Petrie M., Eliezri Y., Campanelli C. Keratoacanthoma of the head and neck with perineural invasion: incidental finding or cause for concern?. Dermatol Surg 2010, 36(7):1209-1213.
6. Garcia-Zuazaga J., Ke M., Lee P. Giant keratoacanthoma of the upper extremity treated with Mohs micrographic surgery: a case report and review of current treatment modalities. J Clin Aesthet Dermatol 2009, 2(8):22-25.
7. Goldberg L.H., Silapunt S., Beyrau K.K., et al. Keratoacanthoma as a postoperative complication of skin cancer excision. J Am Acad Dermatol 2004, 50(5):753-758.
8. Gloster H.M., Harris K.R., Roenigk R.K. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996, 35:82-87.
9. Ratner D., Thomas C.O., Johnson T.M., et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 1997, 37(4):600-613.
10. Robinson J.K. Dermatofibrosarcoma protuberans resected by Mohs' surgery (chemosurgery). A 5-year prospective study. J Am Acad Dermatol 1985, 12(6):1093-1098.
11. Diamantis S.A., Marks V.J. Mohs micrographic surgery in the treatment of microcystic adnexal carcinoma. Dermatol Clin 2011, 29(2):185-190. viii.
12. Friedman P.M., Friedman R.H., Jiang S.B., et al. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol 1999, 41(2 Pt 1):225-231.
13. Chiller K., Passaro D., Scheuller M., et al. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. Arch Dermatol 2000, 136(11):1355-1359.
14. Thomas C.J., Wood G.C., Marks V.J. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience. Dermatol Surg 2007, 33(3):333-339.
15. Leibovitch I., Huilgol S.C., Selva D., et al. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol 2005, 52(2):295-300.
16. Wallace R.D., Bernstein P.E. Microcystic adnexal carcinoma. Ear Nose Throat J 1991, 70(11):789-793.
17. Love W.E., Schmitt A.R., Bordeaux J.S. Management of unusual cutaneous malignancies: atypical fibroxanthoma, malignant fibrous histiocytoma, sebaceous carcinoma, extramammary Paget disease. Dermatol Clin 2011, 29(2):201-216. viii.
18. Seavolt M., McCall M. Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with Mohs micrographic surgery. Dermatol Surg 2006, 32:435-441.
19. Albertini J.G., Elston D.M., Libow L.F., et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg 2002, 28(8):656-665.
20. Snow S.N., Mohs F.E., Oriba H.A., et al. Cutaneous malignant melanoma treated by Mohs surgery. Review of the treatment results of 179 cases from the Mohs Melanoma Registry. Dermatol Surg 1997, 23(11):1055-1060.
21. Chang K.H., Dufresne R., Cruz A., et al. The operative management of melanoma: where does Mohs surgery fit in?. Dermatol Surg 2011, 37(8):1069-1079.
22. Muscarella V.A. Angiosarcoma treated by Mohs micrographic surgery. J Dermatol Surg Oncol 1993, 19(12):1132-1133.
23. Berlin A.L., Amin S.P., Goldberg D.J. Extraocular sebaceous carcinoma treated with Mohs micrographic surgery: report of a case and review of literature. Dermatol Surg 2008, 34(2):254-257.
24. Snow S.N., Larson P.O., Lucarelli M.J., et al. Sebaceous carcinoma of the eyelids treated by Mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg 2002, 28(7):623-631.
25. Lee K.Y., Roh M.R., Chung W.G., et al. Comparison of Mohs micrographic surgery and wide excision for extramammary Paget's disease: Korean experience. Dermatol Surg 2009, 35(1):34-40.
26. Hendi A., Brodland D.G., Zitelli J.A. Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 2004, 51(5):767-773.
27. Brown M.D., Swanson N.A. Treatment of malignant fibrous histiocytoma and atypical fibrous xanthomas with micrographic surgery. J Dermatol Surg Oncol 1989, 15(12):1287-1292.
28. Starling J., Coldiron B.M. Mohs micrographic surgery for the treatment of cutaneous leiomyosarcoma. J Am Acad Dermatol 2011, 64(6):1119-1122.
29. Krunic A.L., Kim S., Medenica M., et al. Recurrent adenoid cystic carcinoma of the scalp treated with Mohs micrographic surgery. Dermatol Surg 2003, 29(6):647-649.
30. Chesser R.S., Bertler D.E., Fitzpatrick J.E., et al. Primary cutaneous adenoid cystic carcinoma treated with Mohs micrographic surgery toluidine blue technique. J Dermatol Surg Oncol 1992, 18(3):175-176.
31. Kim Y.J., Kim A.R., Yu D.S. Mohs micrographic surgery for squamoid eccrine ductal carcinoma. Dermatol Surg 2005, 31(11 Pt 1):1462-1464.
32. Pathai S., Barlow R., Williams G., et al. Mohs' micrographic surgery for Merkel cell carcinomas of the eyelid. Orbit 2005, 24(4):273-275.
33. Boyer J.D., Zitelli J.A., Brodland D.G., et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002, 47(6):885-892.
34. Available at: Accessed July 5, 2011. http://www.aad.org/pm/billing/medicare/_doc/ImpactofLossofMPRRExemptionforMohs.pdf.
35. Available at: Accessed July 5, 2011. http://www.globalacademycme.com/news/skin-allergy-news/single-view/mohs-surgery-in-medicare-patients-skyrocketing/ece6850424092bce77258ed6573b9222.html.
36. Lee D.A., Ratner D. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma. Dermatol Surg 2006, 32(7):916-922. [discussion: 922-3].
37. Ratner D., Bagiella E. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery. Dermatol Surg 2003, 29(9):899-903.
38. Guardiano R.A., Grande D.J. A direct comparison of visual inspection, curettage, and epiluminescence microscopy in determining tumor extent before the initial margins are determined for Mohs micrographic surgery. Dermatol Surg 2010, 36(8):1240-1244.
39. Jih M.H., Friedman P.M., Goldberg L.H., et al. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study. Dermatol Surg 2005, 31(1):10-15.
40. Wright T.I., Baddour L.M., Berbari E.F., et al. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol 2008, 59(3):464-473.
41. Maragh S.L., Brown M.D. Prospective evaluation of surgical site infection rate among patients with Mohs micrographic surgery without the use of prophylactic antibiotics. J Am Acad Dermatol 2008, 59(2):275-278.
42. Rogers H.D., Desciak E.B., Marcus R.P., et al. Prospective study of wound infections in Mohs micrographic surgery using clean surgical technique in the absence of prophylactic antibiotics. J Am Acad Dermatol 2010, 63(5):842-851.
43. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007 Oct 9, 116(15):1736-1754. Epub 2007 Apr 19. Erratum in: Circulation. 2007 Oct 9;116(15):e376-7.
44. Alcalay J., Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue?. Dermatol Surg 2004, 30(8):1091-1094. [discussion: 1094].
45. Hurst E.A., Yu S.S., Grekin R.C., et al. Bleeding complications in dermatologic surgery. Semin Cutan Med Surg 2007, 26(4):189-195.
46. Cook-Norris R.H., Michaels J.D., Weaver A.L., et al. Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation. J Am Acad Dermatol 2011, 65(3):584-591.
47. Lewis K.G., Dufresne R.G. A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery. Dermatol Surg 2008, 34(2):160-164. [discussion: 164-5].
48. Blasdale C., Lawrence C.M. Perioperative international normalized ratio level is a poor predictor of postoperative bleeding complications in dermatological surgery patients taking warfarin. Br J Dermatol 2008, 158(3):522-526.
49. Kirkorian A.Y., Moore B.L., Siskind J., et al. Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons. Dermatol Surg 2007, 33(10):1189-1197.
50. Leibovitch I., Huilgol S.C., Selva D., et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005, 53(3):452-457.
51. Smeets Nicole W.J., Krekels Gertruud A.M., Ostertag Judith U., et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004, 364:1766-1772.
52. Veronese F., Farinelli P., Zavattaro E., et al. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery. J Eur Acad Dermatol Venereol 2011, [Epub ahead of print]. 10.1111/j.1468-3083.2011.04165.x.
53. Rowe D.E., Carroll R.J., Day C.L. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989, 15(4):424-431.
54. Silverman M.K., Kopf A.W., Bart R.S., et al. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992, 18(6):471-476.
55. Rowe D.E., Carroll R.J., Day C.L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989, 15(3):315-328.
56. Mosterd K., Krekels G.A., Nieman F.H., et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008, 9(12):1149-1156.
57. Otley C.C. Mohs' micrographic surgery for basal-cell carcinoma of the face. Lancet 2005, 365(9466):1226-1227. [author reply: 1227].
58. Asgari M.M., Bertenthal D., Sen S., et al. Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg 2009, 35(7):1041-1049.
59. Chren M.M., Sahay A.P., Bertenthal D.S., et al. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 2007, 127:1351-1357.
60. Serup J., Lindblad A.K., Maroti M., et al. To follow or not to follow dermatological treatment-a review of the literature. Acta Derm Venereol 2006, 86:193-197.
61. Renzi C., Picardi A., Abeni D., et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 2002, 138(3):337-342.
62. Asgari MM, Warton EM, Neugabauer R, et al. Predictors of patient satisfaction in Mohs surgery: analysis of pre-, intra- and postoperative factors in a large prospective cohort. Arch Dermatol, in press.
63. Jackson J.L., Chamberlin J., Kroenke K. Predictors of patient satisfaction. Soc Sci Med 2001, 52(4):609-620.
64. Wilson LS, Pregenzer M, Bertenthal D, et al. Costs of non melanoma skin cancer treatments. Derm Surg, in press.
65. Smeets N.W., Kuijpers D.I., Nelemans P., et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face-results of a retrospective study and review of the literature. Br J Dermatol 2004, 151:141-147.
66. Welch M.L., Anderson L.L., Grabski W.J. Evaluation and management of nonmelanoma skin cancer: the military perspective. Dermatol Clin 1999, 17(1):19-28.
67. Cook J., Zitelli J.A. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998, 39(5 Pt 1):698-703.
68. Higashi M.K., Veenstra D.L., Langley P.C. Health economic evaluation of non-melanoma skin cancer and actinic keratosis. Pharmacoeconomics 2004, 22:83-94.
69. Bialy T.L., Whalen J., Veledar E., et al. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. Arch Dermatol 2004, 140:736-742.
70. Lear W., Mittmann N., Barnes E., et al. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study. J Cutan Med Surg 2008, 12:82-87.
71. Bentkover S.H., Grande D.M., Soto H., et al. Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Arch Facial Plast Surg 2002, 4:114-119.
72. Essers Brigitte A.B., Dirksen Carmen D., Nieman Fred H.M., et al. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 2006, 142:187-194.
73. Blázquez-Sánchez N., de Troya-Martín M., Frieyro-Elicegui M., et al. Actas Dermosifiliogr 2010, 101(7):622-628. [in Spanish].